IMPLEVISTA ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.9% 5.7% 4.5% 10.5% 2.4%  
Credit score (0-100)  71 40 45 22 62  
Credit rating  A BBB BBB BB BBB  
Credit limit (kDKK)  0.4 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  2,035 1,695 1,697 423 2,152  
EBITDA  666 138 565 -752 1,210  
EBIT  666 138 565 -752 1,210  
Pre-tax profit (PTP)  696.2 131.1 279.4 -1,309.0 1,131.2  
Net earnings  539.4 99.1 196.8 -1,031.3 879.7  
Pre-tax profit without non-rec. items  696 131 279 -1,309 1,131  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  51.7 27.5 40.3 54.6 30.5  
Shareholders equity total  1,343 1,442 1,539 407 1,287  
Interest-bearing liabilities  620 250 93.8 1,703 710  
Balance sheet total (assets)  3,316 4,816 5,093 3,701 3,168  

Net Debt  -6.8 -1,074 -1,206 1,360 606  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,035 1,695 1,697 423 2,152  
Gross profit growth  -13.3% -16.7% 0.1% -75.0% 408.1%  
Employees  0 0 0 0 4  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,316 4,816 5,093 3,701 3,168  
Balance sheet change%  -29.1% 45.3% 5.8% -27.3% -14.4%  
Added value  666.0 137.9 564.5 -752.0 1,209.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  25 -24 13 14 -24  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 -1.0 1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  32.7% 8.1% 33.3% -177.6% 56.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  17.5% 3.9% 11.7% -16.9% 35.3%  
ROI %  32.1% 8.7% 34.9% -39.8% 59.0%  
ROE %  42.4% 7.1% 13.2% -106.0% 103.8%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  40.5% 29.9% 30.2% 11.0% 40.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -1.0% -778.7% -213.5% -180.9% 50.1%  
Gearing %  46.1% 17.3% 6.1% 418.0% 55.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.2% 6.4% 175.0% 62.9% 6.7%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.7 1.4 1.4 1.1 1.7  
Current Ratio  1.7 1.4 1.4 1.1 1.7  
Cash and cash equivalent  626.4 1,323.9 1,299.3 342.7 104.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  664.7 729.9 423.7 10.1 1,152.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 302  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 302  
EBIT / employee  0 0 0 0 302  
Net earnings / employee  0 0 0 0 220